SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123245
Filing Date
2024-11-07
Accepted
2024-11-07 16:01:41
Documents
59
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vor-20240930.htm   iXBRL 10-Q 1509778
2 EX-10.1 vor-ex10_1.htm EX-10.1 44100
3 EX-31.1 vor-ex31_1.htm EX-31.1 15955
4 EX-31.2 vor-ex31_2.htm EX-31.2 15947
5 EX-32.1 vor-ex32_1.htm EX-32.1 15054
  Complete submission text file 0000950170-24-123245.txt   6089244

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vor-20240930.xsd EX-101.SCH 816788
61 EXTRACTED XBRL INSTANCE DOCUMENT vor-20240930_htm.xml XML 1057839
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39979 | Film No.: 241435390
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)